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Abstract
Introduction: Case reports represent a relevant, timely and important study design 
in advancing medical scientific knowledge. They allow integration between clinical 
practice and clinical epidemiology. We aimed to assess the completeness of reporting 
(COR) of case reports published in high-impact journals. We assessed the COR of 
case reports using the CARE guidelines.
Materials and methods: We selected three high-impact journals and one journal 
specialized in publishing case reports, in which we included all published case re-
ports from July to December 2017. Median COR score was calculated per study, and 
CORs were compared between journals with and without endorsement of CARE 
guidelines.
Results: One hundred and fourteen case reports were included. Overall median COR 
was 81%, IQR [63%-96%]. Sections with the highest COR (84%-100%) were patient 
information, clinical findings, therapeutic intervention, follow-up and outcomes, dis-
cussion and informed consent. Sections with the lowest COR were title, keywords, 
timeline and patient perspective (2%-34%). COR was higher in journals endorsing 
in comparison to those not endorsing CARE guidelines (77% vs 65%), respectively, 
median difference = −12% 95% CI [−16% to −7%].
Discussion: Overall completeness of case reports in included journals is high es-
pecially for CARE endorsing and dedicated journals but reporting of some items 
could be improved. Ongoing and future evaluations of endorsement status of report-
ing guidelines in medical journals should be assessed to improve completeness and 
reduce waste of clinical research, including case reports.
K E Y W O R D S
case report, editorial policies, guideline adherence, guidelines as topics, publishing/standards
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1 |  INTRODUCTION
According to the International Epidemiological Association, 
case reports are detailed descriptions of a few patients or 
clinical cases (frequently, just one sick person) with an un-
usual disease or complication, uncommon combinations 
of diseases, an unusual or misleading semiology, cause or 
outcome (maybe a surprising recovery). They often are pre-
liminary observations that are later refuted and they cannot 
estimate disease frequency or risk (eg for lack of a valid 
denominator).1
However, case reports have a time-honoured and rich tra-
dition in medicine and scientific publication. Case reports 
represent a relevant, timely and important study design in 
advancing medical scientific knowledge, and they allow 
integration between clinical practice and clinical epidemi-
ology.2 Sir William Osler used to outline that medical pro-
fessionals should write and register the unusual about their 
clinical practice and reported it in a short and clear way.3 
Mainly, case reports have historically been important in (a) 
recognizing new, rare and unknown diseases, (b) evaluating 
therapeutic effects, adverse events, surveillance and costs 
of interventions and (c) improving problem-based medical 
education.4
Case report findings are not generalizable, do not address 
causal inference or explanatory mechanisms, and emphasize 
low-probability events. They do not provide strong causal 
evidence in comparison with other designs, such as analyt-
ical observational studies or randomized controlled trials.5 
Nevertheless, they should be reported as complete as possible 
in order to ensure their appropriate assessment and potential 
usefulness.
Case reports comprise a significant proportion of the ar-
ticles in many indexed medical journals. Case report vol-
ume, indexed on Embase and MEDLINE, increased by 45% 
from 49 918 in 2000 to 72 388 in 2010.5,6 This amount of 
publication explains why it is important and pertinent to 
study the completeness and the proper writing of these arti-
cles. It could be a potential and wide way to reduce “waste 
in research”.7
In 2013, the CARE guidelines (Consensus-based Clinical 
Case Reporting Guideline Development) were developed to 
improve that quality and established a systematic tool of com-
pleteness of a case report. Statisticians, methodologists and 
several clinical professionals form the CARE group. Initially, 
they created a checklist that consisted in 13 topics required to 
classify a case report as “complete.” In the last 2016 update, 
a fourteenth topic was added accomplishing with a total of 31 
items (Table 1).8
To the best of our knowledge, completeness of case reports 
has not been widely evaluated and it has only addressed to spe-
cific clinical areas. We found few reports focused on assessment 
of completeness of case reports. Most of them were from Asia 
regarding topics as acupuncture.9,10 Eldawlatly et al evaluated 
completeness of case reports in the Saudi Journal of Anesthesia 
between 2013 and 2017. They concluded that the main topics 
they needed to make an improvement were patients’ perspective 
and obtained consent.11 Ravi et al12 measured the completeness 
in case reports from Indian journals, acknowledging that en-
dorsement to CARE guidelines was low, because of the lack of 
information about them.
Other previous articles have studied the completeness of 
case reports in surgery and dermatology,13,14 which shows 
that not only the awareness about the guidelines, but also the 
analysis of their use and consequent completeness of the ar-
ticles, are topics that need more diffusion and communica-
tion. Overall, completeness of reporting (COR) (according 
to CARE guidelines) was considered acceptable but present-
ing a wide variability among studies. Kim et al as Eldawlatly 
et al found a mean adherence around 75%.3,11 On the other 
hand, An and Ravi et al found that COR was between low and 
acceptable (below 50%).10,12
Our primary objective was to assess the COR of case re-
ports published in high-impact medical journals. In second-
ary analyses, we evaluated whether reporting was better for 
journals that explicitly endorsing the CARE statement in their 
instructions for authors. We hypothesized that completeness 
of case reports published in high-impact medical journals is 
high and above 75%.
2 |  MATERIALS AND METHODS
We searched MEDLINE to find case reports published 
from July to December 2017 in three general medical jour-
nals: JAMA, The Lancet and The New England Journal 
of Medicine (NEJM). Those journals were selected based 
on their relevance and high-impact factor (Journal Impact 
Factor—Clarivate Analytics Impact Factor 2017). In addi-
tion, we included The BMJ Case Reports as a journal explic-
itly dedicated to publish case reports only.
Of the included journals, The BMJ Case Reports and 
JAMA refer explicitly to the CARE statement in their instruc-
tions for authors, whereas The Lancet and The NEJM jour-
nals do not mention the CARE statement. The Lancet requires 
in their submission guidelines to follow several EQUATOR 
guidelines (http://www.equat or-netwo rk.org) without direct 
mention of the CARE guideline.
From the ethical perspective, this paper was classified 
as nonrisk observational research. The abstract, introduc-
tion, certain sections of methods and results, discussion and 
funding proposed by the adapted PRISMA guidelines for re-
porting of meta-epidemiological methodology research were 
fulfilled.15
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2.1 | Data selection
Once journals were selected, two researchers (MV, DO) 
hand-searched in each published issue during the mentioned 
period. All reports of a single case were included. Case re-
ports articles that included more than one patient were ex-
cluded of this study. Disagreements during selection were 
solved by consensus with a third researcher (JAC).
Title and abstract screening were performed including all 
possibly relevant evaluations for further review. Full texts of 
all remaining studies were retrieved and appraised for eligi-
bility. Finally, we exported retrieved citations to Mendeley 
(Elsevier).16
2.2 | Data extraction
The CARE checklist was used to evaluate all case reports. 
In order to train research members (MV and DO), a pilot 
test was performed using 15 case reports not included in this 
study and individual concerns about specific items were dis-
cussed and solved by consensus with a third researcher (JAC) 
until agreement.
Completeness of included case reports was assessed inde-
pendently by two blinded (each other's individual assessment) 
researchers (MV and DO), and data were organized using a 
pre-specified Excel spreadsheet (Microsoft Corp). Each of 
29 items considered by CARE statement was categorized 
T A B L E  1  CARE guideline 2016 checklist*
Topic Item Question
Title 1 The words “case report” should be in the title along with what is of greatest interest in this case
Keywords 2 The key elements of this case in 2-5 keywords
Abstract 3a Introduction—What is unique about this case? What does it add to the medical literature?
3b The main symptoms of the patient and the important clinical findings
3c The main diagnoses, therapeutics interventions and outcomes
3d Conclusion—What are the main “take-away” lessons from this case?
Introduction 4 Brief background summary of this case referencing the relevant medical literature
Patient Information 5a Demographic information (such as age, gender, ethnicity, occupation)
5b Main symptoms of the patient (his or her chief complaints)
5c Medical, family and psychosocial history including co-morbidities and relevant genetic information
5d Relevant past interventions and their outcomes
Clinical Findings 6 Describe the relevant physical examination (PE) findings
Timeline 7 Depict important milestones related to your diagnoses and interventions (table or figure)
Diagnostic Assessment 8a Diagnostic methods (such as PE, laboratory testing, imaging, questionnaires)
8b Diagnostic challenges (such as financial, language or cultural)
8c Diagnostic reasoning including other diagnoses considered
8d Prognostic characteristics (such as staging in oncology) where applicable
Therapeutic Intervention 9a Types of intervention (such as pharmacologic, surgical, preventive, self-care)
9b Administration of intervention (such as dosage, strength, duration)
9c Changes in intervention (with rationale)
Follow-up and Outcomes 10a Clinician-assessed outcomes and when appropriate patient-assessed outcomes
10b Important follow-up test results
10c Intervention adherence and tolerability (How was this assessed?)
10d Adverse and unanticipated events
Discussion 11a Discussion of the strengths and limitations in the management of this case
11b Discussion of the relevant medical literature
11c The rationale for conclusions (including assessment of possible causes)
11d The main “take-away” lessons of this case report
Patient Perspective 12 Did the patient share his or her perspective or experience? (Include when appropriate)
Informed Consent 13 Did the patient give informed consent? Please provide if requested
Additional Information 14 Acknowledgement section; Competing Interests; IRB approval when required
*Source: http://www.care-state ment.org/care-check list.html. 
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as “yes” (reported) or “no” (did not report or could not tell 
something about reporting). Basic study characteristics were 
journal of publication and whether the journal explicitly en-
dorsing CARE statement.
2.3 | Data analysis
Analysis was completed using Excel and R statistical software 
package.17 Descriptive analysis included the number and pro-
portion of manuscripts reporting each of the CARE items.
The “COR score” for each manuscript was calculated as 
the “yes” answers as a proportion of the “yes + no” answers: 
COR score (%) = [yes/(yes + no)] × 100. To calculate COR, 
we used the best scenario assessment of the two blinded eval-
uators. In addition, we reported the proportion of agreement 
for each pair of evaluations and the kappa coefficient that was 
interpreted as minimal agreement (0.21-0.39), weak (0.40-
0.59), moderate (0.60-0.79), strong (0.80-0.90) and almost 
perfect agreement (above 0.90).
Normality of COR scores was checked using distribution 
and probability plots. Median COR score among all questions 
of the CARE statement was calculated, as well as per study 
section. Two secondary analyses were performed. First, we 
compared journals that explicitly endorsed the CARE state-
ment (BMJ Case Reports and JAMA) to journals that did not 
endorse CARE statement (The Lancet and NEJM) by using 
Mann-Whitney U test. A normal approximation of the 95% 
confidence interval of the difference was provided. Second, 
we compared COR scores among the four journals by using 
the Kruskal-Wallis test and multiple post hoc pairwise com-
parisons with the Dunn test. P values and effect sizes are 
presented.
3 |  RESULTS
One hundred and fifty-four papers were screened. Two papers 
were classified as case series reports and were excluded. Of 
these, 114 papers were classified as case reports from July 1 
to December 31 of 2017. They were distributed in BMJ Case 
Reports n = 73 (64%), JAMA n = 17 (15%), The LANCET 
n = 5 (4%) and NEJM n = 19 (17%).
The median COR among all questions was 81%, IQR 
[63%-96%]. Sections with highest median COR were patient 
information (93%), clinical findings (100%), therapeutic in-
tervention (96%), follow-up and outcomes (90%), discussion 
(88%), informed consent (84%) and additional information 
(96%). On the other hand, the sections with lowest mean 
completeness were title (21%), keywords (2%), timeline 
(30%) and patient perspective (17%). At individual questions, 
completeness was below 60% to: question 2, 3a, 3d, 7, 8d, 
(Table 2).
Kappa coefficient presented poor or fair agreement for 18 
items. Ten items showed high proportion of agreement and a 
kappa coefficient at least moderate (items 1, 2, 5b, 6, 8a, 9a, 
10a, 11d, 12 and 13). Mean proportion of agreement among 
31 items was 77% (Table 2).
Case reports published in journals with an explicit ad-
herence to CARE Statement in their instructions to authors 
presented a median COR score higher than journals with-
out explicit endorsing (median  =  77.4% [71-87.1] vs me-
dian = 64.5% [60.5-71]), median difference = −12.8% 95% 
CI [−16.1% to −6.5%], P < .0001.
The distribution of median COR scores of the CARE 
statement in included case reports stratified by journal of 
publication is presented in Figure 1 and detailed COR scores 
for each item of the CARE Statement in Figure 2.
There were differences among COR scores (P < .0001). 
Pairwise comparisons showed that the median COR score 
for BMJ Case Reports was higher than JAMA (median 
difference = 3.9%, P <  .0001), The Lancet (median differ-
ence = 2.4%, P < .0001) and NEJM COR scores (median dif-
ference = 5.3%, P < .0001). We were unable to demonstrate 
differences in other pairwise comparisons.
4 |  DISCUSSION
Although there is still room for improvement in quality 
of reporting of case reports, our study showed that overall 
completeness in reporting is high for CARE endorsing jour-
nals (median COR above 70%). Sections with highest COR 
were patient information, clinical findings, therapeutic inter-
vention, follow-up and outcomes, discussion and informed 
consent. Sections with lowest COR were title, keywords, 
timeline and patient perspective. Journals with explicit en-
dorsing of CARE statement in their instructions to authors 
present a higher COR, which leads to generate recommenda-
tions to improve the completeness of case reports studies in 
the current medical literature.
There is a growing interest in problems affecting the va-
lidity and reliability of published healthcare research.18,19 
Inadequate reporting is a widespread problem and has been 
frequently observed in publications of in vivo and in vitro 
reports as well and a broad range of clinical reports.20,21 In 
2009, Iain Chalmers and Paul Glasziou showed that at least 
50% of research reports were not usable because of incom-
plete reporting.20,22 This waste in research has severe con-
sequences for researchers, clinicians, decision-makers and 
patients. Interestingly, we did not find many published re-
ports about completeness of case reports in the literature.
Older evidence-based medicine paradigms have led us 
to rank study designs based on the level of evidence that 
they represent, with case reports being the lowest. However, 
newer paradigms became less dependent on study design and 
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T A B L E  2  Median completeness of reporting (COR) per topic and proportion of individual COR score of each question of the CARE 
statement in included case reports
Topic Item Question
Median 
COR (%)
Proportion of 
individual COR (%)
Proportion of 
agreement (%)
Kappa 
coefficient
Title 1 The words “case report” should be in 
the title along with what is of greatest 
interest in this case
21 21 93 0.757
Keywords 2 The key elements of this case in 2-5 key 
words
2 2 98 **
Abstract 3a Introduction—What is unique about this 
case? What does it add to the medical 
literature?
59 55 64 0.231
3b The main symptoms of the patient and the 
important clinical findings
63 69 0.385
3c The main diagnoses, therapeutics 
interventions, and outcomes
66 76 0.523
3d Conclusion—What are the main “take-
away” lessons from this case?
54 56 0.000
Introduction 4 Brief background summary of this 
case referencing the relevant medical 
literature
71 71 79 0.560
Patient 
Information
5a Demographic information (such as age, 
gender, ethnicity, occupation)
93 76 79 0.534
5b Main symptoms of the patient (his or her 
chief complaints)
100 97 *
5c Medical, family, and psychosocial history 
including co-morbidities, and relevant 
genetic information
89 71 0.246
5d Relevant past interventions and their 
outcomes
96 75 0.075
Clinical Findings 6 Describe the relevant physical 
examination (PE) findings
100 100 84 *
Timeline 7 Depict important milestones related to 
your diagnoses and interventions (table 
or figure)
30 30 75 0.104
Diagnostic 
Assessment
8a Diagnostic methods (such as PE, 
laboratory testing, imaging, 
questionnaires)
74 100 96 *
8b Diagnostic challenges (such as financial, 
language, or cultural)
68 68 0.369
8c Diagnostic reasoning including other 
diagnoses considered
81 62 0.201
8d Prognostic characteristics (such as staging 
in oncology) where applicable
52 64 0.197
Therapeutic 
Intervention
9a Types of intervention (such as 
pharmacologic, surgical, preventive, 
self-care)
96 100 90 *
9b Administration of intervention (such as 
dosage, strength, duration)
91 61 0.032
9c Changes in intervention (with rationale) 96 70 0.008
(Continues)
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allowed on occasions stronger inferences from well-done 
observational studies.23 Systematic synthesis of case reports 
and case series, when they are the only or best available evi-
dence, is possible24 and may produce adequate inferences.23
Are case reports still useful and should be published? 
John P. Vandenbroucke and Manfred Hauben arguing that 
case reports are still valuable in recognition of new diseases, 
describing new interventions, detection of drug side effects 
(being the pillar for pharmacovigilance), study the mecha-
nisms of the disease, and audit and recognition of rare man-
ifestations of diseases.25 In addition, case reports may have 
a valuable role in medical education (teaching and learning 
from a narrative). The remaining importance of case reports 
reveals a need for improvement of the completeness of their 
reports, being the CARE guidelines the standard for this 
purpose.8,26,27
CARE guidelines are aimed to enhance a complete and 
transparent reporting. Without adequate reporting, it is almost 
impossible to assess reliability and validity of study findings, 
and the strengths and weaknesses of the case, and to use its 
information in practice. A recent initiative addressed both the 
methodological quality (validity) and adequate reporting by 
using a tool organized in four domains: selection, ascertain-
ment, causality and reporting.24 In the last one, their authors 
asked: is the case(s) described with sufficient details to allow 
other investigators to replicate the research or to allow practi-
tioners make inferences related to their own practice? While 
CARE guidelines encourage to publish a complete and mean-
ingful exposition of medical information, this effort advance 
further into the validity analysis of a case report which is only 
possible having a report as complete as possible.
Completeness, quality and reporting guidelines’ adher-
ence has been widely addressed in clinical trials28-30 and ob-
servational studies describing ranges of completeness from 
30 up to 85%.31-34 Considering the limited external validity of 
our results, our estimate of COR for case reports in included 
journals is high specially for CARE endorsing journals.
We demonstrated that COR is above 70% and this is the 
first study evaluating major high-impact general medical 
journals. There are several differences between the analyses 
of each item in the checklist, being the day-to-day practice 
items the ones with the highest COR. These include patient 
information, clinical findings, therapeutic intervention, fol-
low-up and outcomes, discussion; exposing the main inter-
est in publication of these articles, and also, illustrating that 
clinicians are still relying on case reports to help orientate 
challenging cases, mostly due to the lack of patients with 
such diseases. Additionally, we acknowledge that according 
to ethics declarations, like Helsinki and Nuremberg, written 
and informed consent of the patient is one of the items with 
Topic Item Question
Median 
COR (%)
Proportion of 
individual COR (%)
Proportion of 
agreement (%)
Kappa 
coefficient
Follow-up and 
Outcomes
10a Clinician-assessed outcomes and when 
appropriate patient-assessed outcomes
90 100 84 *
10b Important follow-up test results 96 71 0.022
10c Intervention adherence and tolerability 
(How was this assessed?)
76 54 0.067
10d Adverse and unanticipated events 84 57 0.081
Discussion 11a Discussion of the strengths and limitations 
in the management of this case
88 71 68 0.365
11b Discussion of the relevant medical 
literature
98 89 0.179
11c The rationale for conclusions (including 
assessment of possible causes)
96 76 0.089
11d The main “take-away” lessons of this case 
report
80 87 0.664
Patient 
Perspective
12 Did the patient share his or her 
perspective or experience? (Include 
when appropriate)
17 17 83 *
Informed Consent 13 Did the patient give informed consent? 
Please provide if requested
84 84 89 0.683
Additional 
Information
14 Acknowledgement section; Competing 
Interests; IRB approval when required
96 96 89 0.334
**Kappa coefficient not quantifiable (two cells with zero). 
*Kappa coefficient not quantifiable (one cell with zero). 
T A B L E  2  (Continued)
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F I G U R E  1  Distribution of completeness of reporting (COR) scores of the CARE statement in included case reports stratified by journal of 
publication. Data presented as n, median [IQR]
F I G U R E  2  Completeness of reporting (COR) score of the included case reports detailed by items of CARE statement
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high COR. Each included journal has clear policies about 
informed consents for case reports but a few percentages of 
cases do not explain this in detail in the text. Probably, in-
formed consent has been documented towards the editorial 
board of the journal but has not been mentioned in the study 
report.
Items such as inclusion of the words “case report” in the 
title, keywords, timeline and patient perspective had the low-
est COR. First, title and keywords provide an initial overview 
of the manuscript content and could increase the retrieval by 
electronic searches.35 Articles with short titles describing the 
results (related directly to the clinical case) are cited more 
often in literature with two classical examples: (a) “A prelim-
inary communication on extensively disseminated Kaposi's 
sarcoma in a young homosexual man” and (b) “An essay on 
the shaking palsy”.36-38 Second, low COR scores to patient 
perspective may reflect a lack of inclusion of the patient in 
the reporting process, outside of the consent to be published. 
As a source of evidence, case reports must include patient 
perspective as an opportunity to discover patient-reported 
outcomes measures useful for further research.39
Journals with explicit endorsement of CARE state-
ment in their instructions to authors present higher COR. A 
2012 systematic review indicated that for some items of the 
CONSORT checklist, trials published in journals that en-
dorse CONSORT were more completely reported than trials 
published before the time of endorsement or in nonendorsing 
journals.28,40,41 However, Stevens et al assessed if the COR 
was related to journals’ endorsement of reporting guidelines 
including other checklist than previous studies.34 There was 
insufficient evidence to determine the relation between jour-
nals’ endorsement and the COR.
This is one of the few studies that evaluate completeness 
of case reports using CARE guidelines and the first one to 
consider three high-impact international journals. Since 
1990s, PubMed has shown more than 30 000 hits per year 
with the free text “case report” and in 2017 there was more 
than 50 000. Since nothing suggests this diminishes, this is 
an enormous opportunity of improvement in order to reduce 
waste in research and improve utility.42
This study has some limitations. We included three 
high-impact journals and one more dedicated only to publish 
case reports (which accounted for the most of the included 
studies). This fact reduces the external validity of our results 
to the overall literature. Also, selecting well-ranked included 
journals more likely to have adequate reporting may over-
estimate the COR scores in comparison with other journals. 
Finally, our results are not generalizable to other publication 
languages.
We chose only on 6  months’ calendar after the CARE 
guidelines publication and this type of time-period selec-
tion may be limited. We tried to address this restriction by 
addressing an up-to-date time period but this still could be 
insufficient; expanding our study to covering a longer period 
of inclusion, two separate periods, or including some spe-
cialty journals (journals with lower bibliometric indicators) 
may provide valuable information regarding the distribution 
of case report completeness across medical literature and 
strength external validity.
Two journals referring explicitly to the CARE statement 
in their instructions for authors were included. While this 
may be considered as an endorsing of reporting guidelines, 
the process of full implementing is more challenging and it is 
not limited to ask for its use only.43 We hope that our results 
generate discussions regarding the wording of endorsement 
and encourage journals to be clearer in their requests regard-
ing reporting guideline use only.
Our aim was to assess the completeness without con-
sidering other important characteristics of the studies that 
may influence the COR (ie specialty of the clinical case, 
author's details and professional context). Finally, judge-
ments about completeness clearly have a subjective compo-
nent. Completeness about certain topic may be influenced 
by several factors like clinical experience, prior training or 
practicality and transparency of each CARE question. In the 
explanation and elaboration of the CARE guidelines, origi-
nal author's present several examples and each item from the 
checklist is explained and accompanied by published exam-
ples. We took this reference to prior training but our find-
ings showed a high variability in the proportion of agreement 
and kappa coefficients between two evaluators. This finding 
has also been described in observational studies during as-
sessment of COR.44 Studying determinants of COR and in-
creasing the agreement among evaluators (as a way to reduce 
information bias) remain as potential areas of research in 
terms of completeness evaluation studies.
Reduce waste and improve quality of clinical research 
and its following publication is still one of the main goals in 
our current practice. This study aims at providing tools for 
the future publishing completeness of case reports, leading 
us to support the recommendations made by Stevens et al.34 
Ongoing and future evaluations of endorsement status of re-
porting guidelines in medical journals should be assessed to 
improve completeness and reduce waste of clinical research, 
including case reports.
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